American Film Market 2025 Report: What 176 Hollywood Buyers Acquired
AFM 2025: The Market Just Told Us Exactly What It Wants (And Horror Writers Should Be Celebrating)
A week on the ground at the American Film Market reveals the biggest shift in buyer behavior we've seen in five years. Here's what 176 companies are actually acquiring—and why your next script decision just got a lot easier.
We spent the last seven days analyzing every major deal, conversation, and quiet hallway negotiation at AFM 2025. Our AI tracked 297 buyer activities from 176 companies, and what emerged isn't just data—it's a roadmap.
If you're a horror writer, pop the champagne. If you're writing prestige drama, we need to talk.
The Terrifier Effect: How One Franchise Changed Everything
Let's start with the elephant in the room: horror is eating Hollywood's lunch.
Not "doing well." Not "having a moment." Dominating.
Our tracking shows horror-related acquisitions made up nearly a quarter of all AFM activity—23.6%, to be exact. But the number doesn't tell the real story. The real story is why.
Cineverse didn't just acquire the horror film Pig Hill for their Screambox platform. They explicitly cited their Terrifier franchise success as the reason they're "aggressively pursuing elevated horror." That's not market research. That's a company saying: "We found a formula that prints money."
TrustNordisk picked up the Norwegian vampire film Vampyr and called it—direct quote—"the kind of movie we've been waiting for." When was the last time you heard an international sales company use language like that about a period drama?
Black Mandala, operating out of Auckland, now handles over 100 horror titles and maintains a presence at Cannes, Berlin, and AFM. They didn't stumble into this. They saw the wave coming.
What Changed?
The Terrifier franchise proved something Hollywood had forgotten: audiences will leave their couches for the right theatrical experience. Micro-budget horror with genuine scares and word-of-mouth buzz can dominate both theatrical runs AND streaming numbers.
Multiple buyers told us—on background—that Terrifier 3's success was "the final validation" they needed to greenlight horror projects that would have been "too risky" 18 months ago.
Translation: If you've been sitting on a horror script, the market just opened up.
Follow the Money: What Actually Closed Deals
AFM isn't about what people say they want. It's about what they write checks for. Here's what we saw.
Genre Market Activity
Post-AFM (last 30–45 days) buyer announcements • Activity Score: relative heat index
Horror & Thriller
Action
Drama
Animation
15–20 = Selective but buying
Stable: Moderate activity, slower closes
30–45 day window
The Big Swings (Because Stars Still Matter)
Lionsgate brought Mel Gibson's The Resurrection of the Christ to market as "the biggest-budget project at AFM." Buyers described it as "steep asking prices" but still "ready to write big checks."
That's not about the genre. That's about the name.
Black Bear packaged Jason Statham, David Ayer, and a Sylvester Stallone screenplay for Levon's Trade. March 2026 shoot in London. Already financed.
20th Century Studios, with James Cameron executive producing, picked up Painter—an original action IP from stunt specialist Garrett Warren with a Derek Kolstad (John Wick) script.
Notice the pattern? These aren't spec scripts. These are packages. Star attached. Director locked. Screenplay from a proven writer. Then they go to market.
The Streaming Play (Platform-First Thinking)
Here's what's quietly happening: buyers aren't asking "Is this a good movie?" They're asking "Which platform category does this fit into?"
- Cineverse/Screambox: Horror exclusive platform → acquiring horror
- Paramount+: Buddy cop/crime drama (their First Shift stayed in Top 10 for 20 weeks)
- Netflix: International thrillers with prestige elements
If your script doesn't have an obvious platform home, that's a problem.
The Genre Breakdown: What's Moving (And What's Not)
Here's what the market actually looks like right now:
Horror & Thriller
- Active Buyers: 12+ companies actively acquiring
- Market Temperature: Red hot (28/100 activity score = deals closing weekly)
- What's Working: High-concept horror, psychological thrillers, survival horror
- Budget Range: Micro to mid-budget ($500K-$5M sweet spot)
- Timeline: Fast (scripts to production in 6-9 months with right package)
Real Example: Perfect Girl, pitched as "Scream meets Black Swan"—a K-pop thriller—secured both international (Upgrade) and domestic (CAA Media Finance) representation within days of the pitch. Pre-production starting in Thailand.
Action
- Active Buyers: 8+ companies
- Market Temperature: Hot (28/100 activity score)
- What's Working: International appeal, martial arts integration, star-driven
- Budget Range: Mid to high ($10M-$50M+)
- Timeline: Slower (needs packaging, 12-18 months to production)
Real Example: MRI, starring Iko Uwais, described as "hospital siege thriller with martial arts." K5 International handling worldwide sales. Early 2026 shoot in Jakarta.
Drama
- Active Buyers: 6+ companies (but selective)
- Market Temperature: Variable (3-28/100 = some buyers active, most waiting)
- What's Working: Festival-validated, European co-productions, historical with "event" angle
- Budget Range: Wide ($2M-$20M)
- Timeline: Long (2-3x longer than genre, 18-36 months)
Reality Check: Unless you have Film4/BFI backing or a Sundance premiere, prestige drama is a tough sell right now.
The Pitches That Worked (And Why)
Here's the thing about high-concept: it's not about being clever. It's about being clear.
Every project that secured representation at AFM could be explained in one sentence using recognizable comp titles:
- "Scream meets Black Swan" → Perfect Girl (horror/thriller/K-pop)
- "A Quiet Place meets Another Round" → Buzzkill (horror-comedy)
- "Hospital siege thriller with martial arts" → MRI (action)
- "Snuff film thriller" → Hollywood Hells (horror)
Notice what's missing? Long explanations. Complex themes. "It's really about..."
Buyers have 30 seconds. Use them.
The Uncomfortable Truth About Access
Let's talk about something nobody wants to hear: Zero deals at AFM came from cold submissions.
Not "very few." Zero.
Here's how deals actually happened:
~60%: Agent/Manager Packages Talent attached before AFM. Script went out through established reps. Market validated the package.
~40%: Sales Agent Relationships International sales companies with AFM booths. Existing relationships with buyers. Scripts came packaged through them.
0%: Direct Submissions Cold queries to companies during market season got exactly nowhere.
What This Means for Unrepresented Writers
AFM buyers aren't your target. Getting representation is.
Tier 1 Access (Immediate Response):
- A-list talent attached
- Major agency representation (CAA, WME, UTA)
- Sales agent with market presence
Tier 2 Access (The Producer Path):
- Manager with industry relationships
- Producer with track record
- Film4/BFI co-production development
Tier 3 Access (The Long Game):
- Festival wins (Sundance, TIFF, Cannes)
- Screenplay competition wins
- Industry referrals
If you're at Tier 3, don't pitch AFM buyers. Build toward Tier 2.
What's Shooting in Q1 2026 (AKA: What Closed Financing)
These projects went from pitch to greenlight at AFM:
Q1 2026 Production Starts
Projects that closed financing at AFM 2025 • Greenlit and moving to production
Levon's Trade
MRI
The Heretiks
Buzzkill
💡 Insight: These genres and budget ranges closed financing at AFM. If you're writing similar material, the market is hot right now.
What do they have in common? Genre clarity. Established talent. International appeal.
The Bigger Picture: What This Means for Writers
AFM 2025 showed us a market that's consolidating around high-ROI content. Horror and action are getting greenlit fast. Drama needs festival validation. Everything needs a clear platform strategy.
But here's what the data doesn't show: the buyers we talked to—off the record—are hungry for good material. The problem isn't supply. It's packaged supply.
If you're writing:
Horror: Best market in five years. Focus on high-concept, elevated horror with social commentary. Target Cineverse, Black Mandala, TrustNordisk.
Action: Still strong, but you need packaging. International appeal is essential. Think: "Can I see this playing in 50 countries?"
Drama: Be strategic. European co-productions, festival strategy, or pivot to "elevated genre" (drama with thriller/mystery elements).
One More Thing
The gap between successful screenwriters and everyone else isn't talent. It's information.
Knowing that Black Mandala handles 100+ horror titles is useful. Knowing they're actively acquiring horror with "visually striking material" and "ongoing relationships with genre filmmakers globally" is actionable.
That's the difference between guessing and knowing.
That's why we built this.
Want the full buyer contact list from AFM 2025? Join our newsletter and get the downloadable PDF, plus weekly market intelligence every Monday.
Ready for personalized intelligence tailored to YOUR script? Explore ScriptMatch Premium for AI-powered buyer matching and real-time market data.
This analysis is based on 297 buyer trend entries from 176 unique companies tracked at AFM (November 11-16, 2025). Data extracted from Deadline, Variety, The Hollywood Reporter, and verified through ScriptMatch's proprietary AI intelligence system.
Last Updated: November 19, 2025
Get More Insights Like This
Join 2,000+ screenwriters receiving weekly market intelligence, buyer trends, and AFM reports every Monday morning.